会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • Novel crystal forms of substituted phenylalkanoic acids and process for producing the same
    • 取代苯基链烷酸的新型晶体形式及其制备方法
    • US20080070967A1
    • 2008-03-20
    • US11826999
    • 2007-07-19
    • Yuichi ArimotoNaoyuki IshiiMotoshi Shoda
    • Yuichi ArimotoNaoyuki IshiiMotoshi Shoda
    • A61K31/415C07D231/56
    • C07D231/56
    • [Object] In the case of using 3-[3-amino-4-(indan-2-yloxy)-5-(1-methyl-1H-indazol-5-yl)phenyl]propionic acid, methyl 3-[4-(indan-2-yloxy)-3-(1-methyl-1H-indazol-5-yl)-5-nitrophenyl]propionate, or methyl 3-[3-amino-4-(indan-2-yloxy)-5-(1-methyl-1H-indazol-5-yl)phenyl]propionate as a medicine, more preferable aspects or improved methods are provided. [Means] Crystals of any compound among 3-[3-amino-4-(indan-2-yloxy)-5-(1-methyl-1H-indazol-5-yl)phenyl]propionic acid, methyl 3-[4-(indan-2-yloxy)-3-(1-methyl-1H-indazol-5-yl)-5-nitrophenyl]propionate, and methyl 3-[3-amino-4-(indan-2-yloxy)-5-(1-methyl-1H-indazol-5-yl)phenyl]propionate, and methods of producing the same are provided.
    • 在使用3- [3-氨基-4-(茚满-2-基氧基)-5-(1-甲基-1H-吲唑-5-基)苯基]丙酸的情况下,将3- [4 - (茚满-2-基氧基)-3-(1-甲基-1H-吲唑-5-基)-5-硝基苯基]丙酸乙酯或3- [3-氨基-4-(茚满-2-基氧基) - 5-(1-甲基-1H-吲唑-5-基)苯基]丙酸乙酯作为药物,提供更优选的方面或改进的方法。 [表示] 3- [3-氨基-4-(茚满-2-基氧基)-5-(1-甲基-1H-吲唑-5-基)苯基]丙酸的3- [4 - (茚满-2-基氧基)-3-(1-甲基-1H-吲唑-5-基)-5-硝基苯基]丙酸乙酯和3- [3-氨基-4-(茚满-2-基氧基) - 5-(1-甲基-1H-吲唑-5-基)苯基]丙酸酯及其制备方法。
    • 3. 发明授权
    • Crystals of substituted phenylalkanoic acid and method of producing the same
    • 取代苯基链烷酸的晶体及其制备方法
    • US07754752B2
    • 2010-07-13
    • US12483814
    • 2009-06-12
    • Yuichi ArimotoNaoyuki IshiiMotoshi Shoda
    • Yuichi ArimotoNaoyuki IshiiMotoshi Shoda
    • A61K31/416C07D231/56
    • C07D231/56
    • In the case of using 3-[3-amino-4-(indan-2-yloxy)-5-(1-methyl-1H-indazol-5-yl)phenyl]propionic acid, methyl 3-[4-(indan-2-yloxy)-3-(1-methyl-1H-indazol-5-yl)-5-nitrophenyl]propionate, or methyl 3-[3-amino-4-(indan-2-yloxy)-5-(1-methyl-1H-indazol-5-yl)phenyl]propionate as a medicine, more preferable aspects or improved methods are provided.Crystals of any compound among 3-[3-amino-4-(indan-2-yloxy)-5-(1-methyl-1H-indazol-5-yl)phenyl]propionic acid, methyl 3-[4-(indan-2-yloxy)-3-(1-methyl-1H-indazol-5-yl)-5-nitrophenyl]propionate, and methyl 3-[3-amino-4-(indan-2-yloxy)-5-(1-methyl-1H-indazol-5-yl)phenyl]propionate, and methods of producing the same are provided.
    • 在使用3- [3-氨基-4-(茚满-2-基氧基)-5-(1-甲基-1H-吲唑-5-基)苯基]丙酸的情况下,使用3- [4-(茚满) -2-氧基)-3-(1-甲基-1H-吲唑-5-基)-5-硝基苯基]丙酸乙酯或3- [3-氨基-4-(茚满-2-基氧基)-5-( 1-甲基-1H-吲唑-5-基)苯基]丙酸乙酯,更优选的方案或改进的方法。 3- [3-氨基-4-(茚满-2-基氧基)-5-(1-甲基-1H-吲唑-5-基)苯基]丙酸,3- [4-(茚满酮)的任何化合物的晶体 -2-基氧基)-3-(1-甲基-1H-吲唑-5-基)-5-硝基苯基]丙酸甲酯和3- [3-氨基-4-(茚满-2-基氧基)-5-( 1-甲基-1H-吲唑-5-基)苯基]丙酸乙酯及其制备方法。
    • 4. 发明授权
    • Crystal forms of substituted phenylalkanoic acids and process for producing the same
    • 取代苯基链烷酸的晶体形式及其制备方法
    • US07560478B2
    • 2009-07-14
    • US11826999
    • 2007-07-19
    • Yuichi ArimotoNaoyuki IshiiMotoshi Shoda
    • Yuichi ArimotoNaoyuki IshiiMotoshi Shoda
    • A61K31/416C07D231/56
    • C07D231/56
    • In the case of using 3-[3-amino-4-(indan-2-yloxy)-5-(1-methyl-1H-indazol-5-yl)phenyl]propionic acid, methyl 3-[4-(indan-2-yloxy)-3-(1-methyl-1H-indazol-5-yl)-5-nitrophenyl]propionate, or methyl 3-[3-amino-4-(indan-2-yloxy)-5-(1-methyl-1H-indazol-5-yl)phenyl]propionate as a medicine, more preferable aspects or improved methods are provided.Crystals of any compound among 3-[3-amino-4-(indan-2-yloxy)-5-(1-methyl-1H-indazol-5-yl)phenyl]propionic acid, methyl 3-[4-(indan-2-yloxy)-3-(1-methyl-1H-indazol-5-yl)-5-nitrophenyl]propionate, and methyl 3-[3-amino-4-(indan-2-yloxy)-5-(1-methyl-1H-indazol-5-yl)phenyl]propionate, and methods of producing the same are provided.
    • 在使用3- [3-氨基-4-(茚满-2-基氧基)-5-(1-甲基-1H-吲唑-5-基)苯基]丙酸的情况下,使用3- [4-(茚满) -2-氧基)-3-(1-甲基-1H-吲唑-5-基)-5-硝基苯基]丙酸乙酯或3- [3-氨基-4-(茚满-2-基氧基)-5-( 1-甲基-1H-吲唑-5-基)苯基]丙酸乙酯,更优选的方案或改进的方法。 3- [3-氨基-4-(茚满-2-基氧基)-5-(1-甲基-1H-吲唑-5-基)苯基]丙酸,3- [4-(茚满酮)的任何化合物的晶体 -2-基氧基)-3-(1-甲基-1H-吲唑-5-基)-5-硝基苯基]丙酸甲酯和3- [3-氨基-4-(茚满-2-基氧基)-5-( 1-甲基-1H-吲唑-5-基)苯基]丙酸乙酯及其制备方法。